Ivabradine in Stable Coronary Artery Disease without Clinical Heart Failure
Open accessAbstract
BACKGROUND: An elevated heart rate is an established marker of cardiovascular risk. Previous analyses have suggested that ivabradine, a heart-rate-reducing agent, may improve outcomes in patients with stable coronary artery disease, left ventricular dysfunction, and a heart rate of 70 beats per minute or more. METHODS: We conducted a randomized, double-blind, placebo-controlled trial of ivabradine, added to standard background therapy, in 19,102 patients who had both stable coronary artery disease without clinical heart failure and a heart rate of 70 beats per minute or more (including 12,049 patients with activity-limiting angina [class ≥II on the Canadian Cardiovascular Society scale, which ranges from I to IV, with higher classes indicating greater limitations on physical activity owing to angina]). We randomly assigned patients to placebo or ivabradine, at a dose of up to 10 mg twice daily, with the dose adjusted to achieve a target heart rate of 55 to 60 beats per minute. The primary end point was a composite of death from cardiovascular causes or nonfatal myocardial infarction. RESULTS: At 3 months, the mean (±SD) heart rate of the patients was 60.7±9.0 beats per minute in the ivabradine group versus 70.6±10.1 beats per minute in the placebo group. After a median follow-up of 27.8 months, there was no significant difference between the ivabradine group and the placebo group in the incidence of the primary end point (6.8% and 6.4%, respectively; hazard ratio, 1.08; 95% confidence interval, 0.96 to 1.20; P=0.20), nor were there significant differences in the incidences of death from cardiovascular causes and nonfatal myocardial infarction. Ivabradine was associated with an increase in the incidence of the primary end point among patients with activity-limiting angina but not among those without activity-limiting angina (P=0.02 for interaction). The incidence of bradycardia was higher with ivabradine than with placebo (18.0% vs. 2.3%, P<0.001). CONCLUSIONS: Among patients who had stable coronary artery disease without clinical heart failure, the addition of ivabradine to standard background therapy to reduce the heart rate did not improve outcomes. (Funded by Servier; SIGNIFY Current Controlled Trials number, ISRCTN61576291.).
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
For the indication of stable coronary disease, none of the antianginal medications have been shown to reduce the risk of mortality or myocardial infarction.
“For the indication of stable coronary disease, none of these medications have been shown to reduce the risk of mortality or myocardial infarction.”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [249]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Swedberg, K., Komajda, M., Böhm, M., Borer, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61198-1 · Cited by 2,563 · see citing works
Self-citationGibbons, R. J., Abrams, J., Chatterjee, K., Daley, J., DEEDWANIA, P. C., Douglas, J. S., Ferguson, T. B., Fihn, S. D., Fraker, T. D., Gardin, J. M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02848-6 · Cited by 1,688 · see citing works
Guidelines on the management of stable angina pectoris: executive summary
Authors/Task Force Members, Fox, K. M., Garcia, M. A. A., Ardissino, D., Buszman, P. E., Camici, P. G., Crea, F., Daly, C., Backer, G. D., Hjemdahl, P., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,324 · see citing works
Self-citationHeart rate and cardiovascular mortality: The Framingham study
Kannel, W. B., Kannel, C., Paffenbarger, R. S., & Cupples, L. A. (1987) · American Heart Journal · doi:10.1016/0002-8703(87)90666-1 · Cited by 1,292 · see citing works
Böhm, M., Swedberg, K. B., Michel Komajda, N., BORER, J. S., Ford, I., Dubost-Brama, A., Lerebours, G., & Tavazzi, L. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61259-7 · Cited by 1,100 · see citing works
Self-citationFox, K., Ford, I., Steg, P. G., Tendera, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61170-8 · Cited by 1,099 · see citing works
Self-citationResting Heart Rate in Cardiovascular Disease
Fox, K., Borer, J. S., Camm, A. J., Danchin, N., Ferrari, R., Lopez Sendon, J. L., Steg, P. G., Tardif, J.-C., Tavazzi, L., & Tendera, M. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.04.079 · Cited by 1,062 · see citing works
Self-citationDiaz, A., Bourassa, M. G., Guertin, M.-C., & Tardif, J.-C. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi190 · Cited by 790 · see citing works
Self-citationFox, K., Ford, I., Steg, P. G., Tendera, M., Robertson, M., & Ferrari, R. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61171-x · Cited by 789 · see citing works
Self-citationTardif, J., Ford, I., Tendera, M., Bourassa, M. G., & Fox, K. M. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi586 · Cited by 580 · see citing works
Self-citationMeta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., & Armstrong, P. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00006 · Cited by 481 · see citing works
β-Blocker Use and Clinical Outcomes in Stable Outpatients With and Without Coronary Artery Disease
Bangalore, S., Steg, G., Deedwania, P., Crowley, K., Eagle, K. A., Goto, S., Ohman, E. M., Cannon, C. P., Smith, S. C., Zeymer, U., et al. (2012) · JAMA · doi:10.1001/jama.2012.12559 · Cited by 436 · see citing works
Self-citationTardif, J., Ponikowski, P. P., Kahan, T., & for the ASSOCIATE study Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehn571 · Cited by 338 · see citing works
Self-citationKolloch, R. E., Legler, U. F., Champion, A., COOPERDEHOFF, R., Handberg, E. M., Zhou, Q., & Pepine, C. J. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehn123 · Cited by 330 · see citing works
Swedberg, K. B., Michel Komajda, N., Böhm, M., BORER, J. S., Robertson, M., Tavazzi, L., & Ford, I. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.01.020 · Cited by 262 · see citing works
Self-citationFox, K. M., Ford, I., Steg, P. G., Tendera, M., Robertson, M., Ferrari, R., & on behalf of the BEAUTIFUL Investigators (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp358 · Cited by 223 · see citing works
Self-citationFunny channels in the control of cardiac rhythm and mode of action of selective blockers
DiFrancesco, D. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.006 · Cited by 202 · see citing works
Heart rate: a forgotten link in coronary artery disease?
Fox, K. M., & Ferrari, R. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.58 · Cited by 90 · see citing works
Self-citationFox, K. M., Ford, I., Steg, P. G., Tardif, J., Tendera, M., & Ferrari, R. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.06.024 · Cited by 33 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [14]14. Fox K, Garcia MA, Ardissino D, et al. Copyright © 2014 Massachusetts Medical Society. RECEIVE IMMEDIATE NOTIFICATION WHEN AN ARTICLE IS PUBLISHED ONLINE FIRST To be notified by e-mail when Journal articles are published Online First, sign up at NEJM.org. n engl j med 371;12 nejm.org september 18 , 2014
Cited by
Sorted by citations
McDonagh, T. A., Metra, M., Adamo, M., Gardner, R. S., Baumbach, A., Böhm, M., Burri, H., Butler, J., Čelutkienė, J., Chioncel, O. D., et al. (2021) · PubMed · doi:10.1093/eurheartj/ehab670 · Cited by 19,618 · see citing works
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw128 · Cited by 11,429 · see citing works
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166 · see citing works
2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González-Juanatey, J. R., Harjola, V.-P., Jankowska, E. A., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.592 · Cited by 5,866 · see citing works
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922 · see citing works
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,476 · see citing works
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C. J., Andreotti, F., Koskinas, K. C., Rosselló, X., Adamo, M., Ainslie, J., BANNING, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 3,314 · see citing works
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000509 · Cited by 3,109 · see citing works
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.12.012 · Cited by 2,862 · see citing works
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations
Boudoulas, K. D., BORER, J. S., & Boudoulas, H. K. (2015) · Cardiology · doi:10.1159/000435947 · Cited by 1,952 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · see citing works
Chioncel, O., Lainscak, M., Seferovic, P. M., Anker, S. D., Crespo-Leiro, M. G., Harjola, V.-P., Parissis, J., Laroche, C., Piepoli, M. F., Fonseca, C., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.813 · Cited by 927 · see citing works
Self-citationYancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000435 · Cited by 899 · see citing works
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 769 · see citing works
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.011 · Cited by 614 · see citing works
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.003 · Cited by 596 · see citing works
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Ponikowski, P. P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., Falk, V., González‐Juanatey, J. R., Harjola, V., Jankowska, E. A., et al. (2016) · Kardiologia Polska · doi:10.5603/kp.2016.0141 · Cited by 450 · see citing works
Cai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 436 · see citing works
Macrophages in cardiovascular diseases: molecular mechanisms and therapeutic targets
Chen, R., Zhang, H., Tang, B., Luo, Y., Yang, Y., Zhong, X., Chen, S., Xu, X., Huang, S., & Liu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01840-1 · Cited by 387 · see citing works
Maddox, T. M., Januzzi, J. L., Allen, L. A., Breathett, K., Brouse, S., Butler, J., Davis, L. L., Fonarow, G. C., Ibrahim, N. E., Lindenfeld, J., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.12.024 · Cited by 362 · see citing works
Zhang, D., Shen, X., & Qi, X. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150535 · Cited by 329 · see citing works
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304 · see citing works
The Primary Outcome Fails — What Next?
Pocock, S., & Stone, G. W. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1510064 · Cited by 273 · see citing works
Resting Heart Rate: Risk Indicator and Emerging Risk Factor in Cardiovascular Disease
Böhm, M., Reil, J.-C., Deedwania, P., Kim, J. B., & Borer, J. S. (2015) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.09.016 · Cited by 236 · see citing works
Hemingway, H., Asselbergs, F. W., Danesh, J., Dobson, R., Maniadakis, N., Maggioni, A. P., van Thiel, G. J. M. W., Cronin, M., Brobert, G., Vardas, P. E., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx487 · Cited by 212 · see citing works
The Clinical Use of Ivabradine
Koruth, J. S., Lala, A., Pinney, S., Reddy, V. Y., & Dukkipati, S. R. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.038 · Cited by 185 · see citing works
A 'diamond' approach to personalized treatment of angina
Ferrari, R., Camici, P. G., Crea, F., Danchin, N., Fox, K. M., Maggioni, A. P., Manolis, A. J., Marzilli, M., Rosano, G. M. C., & Lopez-Sendon, J. L. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.131 · Cited by 173 · see citing works
Self-citationLong-Term Use of Cardiovascular Drugs
Rosselló, X., Pocock, S., & Julian, D. G. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.018 · Cited by 167 · see citing works
Effect of Selective Heart Rate Slowing in Heart Failure With Preserved Ejection Fraction
Pal, N., Sivaswamy, N., Mahmod, M., Yavari, A., Rudd, A. E., Singh, S., Dawson, D. K., Francis, J. M., Dwight, J. S., Watkins, H. C., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.017119 · Cited by 148 · see citing works
Eppinga, R. N., Hagemeijer, Y. P., Burgess, S., Hinds, D. A., Stefánsson, K., Gudbjartsson, D. F., van Veldhuisen, D. J., Munroe, P. B., Verweij, N., & van der Harst, P. (2016) · Nature Genetics · doi:10.1038/ng.3708 · Cited by 148 · see citing works
Sartiani, L., Mannaioni, G., Masi, A., Novella Romanelli, M., & Cerbai, E. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.014035 · Cited by 143 · see citing works
Isoproterenol‐induced cardiac ischemia and fibrosis: Plant‐based approaches for intervention
Allawadhi, P., Khurana, A., Sayed, N., Kumari, P., & Godugu, C. (2018) · Phytotherapy Research · doi:10.1002/ptr.6152 · Cited by 130 · see citing works
Michos, E. D., Reddy, T. K., Gulati, M., Brewer, L. C., Bond, R. M., Velarde, G., Bailey, A. L., Echols, M. R., Nasser, S. A., Bays, H. E., et al. (2021) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2021.100250 · Cited by 126 · see citing works
Coronary Atherosclerosis: Pathophysiologic Basis for Diagnosis and Management
Boudoulas, K. D., Triposkiadis, F. K., Geleris, P., & Boudoulas, H. K. (2016) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2016.04.003 · Cited by 122 · see citing works
Batta, A., Hatwal, J., Batta, A., Verma, S., & Sharma, Y. P. (2023) · World Journal of Cardiology · doi:10.4330/wjc.v15.i5.229 · Cited by 116 · see citing works
Importance of resting heart rate
Olshansky, B., Ricci, F., & Fedorowski, A. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2022.05.006 · Cited by 109 · see citing works
The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases
Strauss, M. H., Hall, A. S., & Narkiewicz, K. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07248-1 · Cited by 108 · see citing works
Heart rate reduction in coronary artery disease and heart failure
Ferrari, R., & Fox, K. M. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.84 · Cited by 106 · see citing works
Self-citationHeart rate as a predictor of cardiovascular risk
Tadic, M., Cuspidi, C., & Grassi, G. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12892 · Cited by 97 · see citing works
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2016) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2016.07.001 · Cited by 91 · see citing works
Elevated heart rate and nondipping heart rate as potential targets for melatonin: a review
Šimko, F., Baka, T., Paulis, L., & Reiter, R. J. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12348 · Cited by 88 · see citing works
Resting heart rate, heart rate variability and functional decline in old age
Ogliari, G., Mahinrad, S., Stott, D. J., Jukema, J. W., Mooijaart, S. P., Macfarlane, P. W., Clark, E., Kearney, P. M., Westendorp, R. G. J., de Craen, A. J. M., et al. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.150462 · Cited by 87 · see citing works
Ohman, E. M. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1502240 · Cited by 87 · see citing works
Kloner, R. A., & CHAITMAN, B. R. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416679733 · Cited by 86 · see citing works
hERG Potassium Channel Blockade by the HCN Channel Inhibitor Bradycardic Agent Ivabradine
Melgari, D., Brack, K. E., Zhang, C., Zhang, Y., Harchi, A. E., Mitcheson, J. S., Dempsey, C. E., Ng, G. A., & Hancox, J. C. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001813 · Cited by 82 · see citing works
Heart Rate and Heart Failure With Preserved Ejection Fraction
Meyer, M., & LeWinter, M. M. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.006213 · Cited by 81 · see citing works
Treatment of Angina: Where Are We?
Balla, C., Pavasini, R., & Ferrari, R. (2018) · Cardiology · doi:10.1159/000487936 · Cited by 77 · see citing works
Self-citationResting heart rate and relation to disease and longevity: past, present and future
Jensen, M. T. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1566567 · Cited by 77 · see citing works
Joo, S., Kim, S., Choi, J., Park, H.-K., Beom, J. W., Lee, J.-G., Chae, S. C., Kim, H.-S., Kim, Y. J., Cho, M., et al. (2020) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvaa029 · Cited by 75 · see citing works
Overview of Cardiac Arrhythmias and Treatment Strategies
Kingma, J. G., Simard, C., & Drolet, B. (2023) · Pharmaceuticals · doi:10.3390/ph16060844 · Cited by 75 · see citing works
HCN Channels Modulators: The Need for Selectivity
Novella Romanelli, M., Sartiani, L., Masi, A., Mannaioni, G., Manetti, D., Mugelli, A., & Cerbai, E. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616999160315130832 · Cited by 73 · see citing works
β-Blockers, heart disease and COPD: current controversies and uncertainties
Baker, J. G., & Wilcox, R. G. (2016) · Thorax · doi:10.1136/thoraxjnl-2016-208412 · Cited by 72 · see citing works
Ivabradine for the Treatment of Cardiovascular Diseases
Ide, T., Ohtani, K., Higo, T., Tanaka, M., Kawasaki, Y., & Tsutsui, H. (2018) · Circulation Journal · doi:10.1253/circj.cj-18-1184 · Cited by 71 · see citing works
Pleiotropic, heart rate‐independent cardioprotection by ivabradine
Kleinbongard, P., Gedik, N., Witting, P. K., Freedman, B., Klöcker, N., & Heusch, G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13220 · Cited by 71 · see citing works
Psotka, M. A., & Teerlink, J. R. (2016) · Circulation · doi:10.1161/circulationaha.115.018094 · Cited by 66 · see citing works
Mesnier, J., Ducrocq, G., Danchin, N., Ferrari, R., Ford, I., Tardif, J., Tendera, M., Fox, K. M., Steg, P. G., & for the CLARIFY Investigators (2021) · Circulation · doi:10.1161/circulationaha.121.054567 · Cited by 63 · see citing works
Self-citationBig biomedical data and cardiovascular disease research: opportunities and challenges
Denaxas, S., & Morley, K. I. (2015) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcv005 · Cited by 62 · see citing works
Pharmacological and emerging therapies in the treatment of chronic angina
Husted, S., & Ohman, E. M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61283-1 · Cited by 60 · see citing works
When an Increase in Central Systolic Pressure Overrides the Benefits of Heart Rate Lowering
Messerli, F. H., Rimoldi, S. F., Bangalore, S., Bavishi, C., & Laurent, S. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.610 · Cited by 59 · see citing works
HCN Channels—Modulators of Cardiac and Neuronal Excitability
Herrmann, S., Schnorr, S., & Ludwig, A. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16011429 · Cited by 57 · see citing works
Böhm, M., Schumacher, H., Teo, K. K., Lonn, E. M., Mahfoud, F., Ukena, C., Mann, J. F. E., Mancia, G., Redon, J., Schmieder, R. E., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehy808 · Cited by 55 · see citing works
O’Fee, K., Deych, E., Ciani, O., & Brown, D. (2021) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2021.5726 · Cited by 54 · see citing works
Ivabradine (Corlanor) for Heart Failure: The First Selective and Specific I f Inhibitor.
Tse, S., & Mazzola, N. (2015) · PubMed Central · Cited by 52 · see citing works
Barillà, F., Pannarale, G., Torromeo, C., Paravati, V., Acconcia, M. C., Tanzilli, G., Mangieri, E., Dominici, T., Martino, F., Pannitteri, G., et al. (2016) · Clinical Drug Investigation · doi:10.1007/s40261-016-0424-9 · Cited by 51 · see citing works
Fox, K. M., Ford, I., Steg, P. G., Tardif, J., Tendera, M., & Ferrari, R. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv451 · Cited by 51 · see citing works
Self-citationHeart Rate and its Reduction in Chronic Heart Failure and Beyond
Vukadinović, A. N., Vukadinović, D., BORER, J. S., Cowie, M., Michel Komajda, N., Lainščak, M., Swedberg, K. B., & Böhm, M. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.902 · Cited by 51 · see citing works
Pharmacologic Management for Ventricular Arrhythmias: Overview of Anti-Arrhythmic Drugs
Larson, J. D., Rich, L., Deshmukh, A., Judge, E. C., & Liang, J. J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113233 · Cited by 50 · see citing works
Optimizing Management of Stable Angina
Montone, R. A., Rinaldi, R., Niccoli, G., Andò, G., Gragnano, F., Piccolo, R., Pelliccia, F., Moscarella, E., Zimarino, M., Fabris, E., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.06.015 · Cited by 50 · see citing works
Tanboğa, İ. H., Topçu, S., Aksakal, E., Gülcü, O., Aksakal, E., Aksu, U., Oduncu, V., Ulusoy, F. R., Sevimli, S., & Kaymaz, C. (2016) · Clinical Cardiology · doi:10.1002/clc.22578 · Cited by 48 · see citing works
Medical treatment of stable angina: A tailored therapeutic approach
Manolis, A. J., Poulimenos, L. E., Ambrosio, G., Kallistratos, M. S., López-Sendón, J., Dechend, R., Mancia, G., & Camm, A. J. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.06.150 · Cited by 47 · see citing works
Management of Stable Angina – Current Guidelines: A Critical Appraisal
Thadani, U. (2016) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-016-6681-2 · Cited by 47 · see citing works
Dharod, A., Soliman, E. Z., Dawood, F., Chen, H., Shea, S., Nazarian, S., Bertoni, A. G., & for the MESA Investigators (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7655 · Cited by 45 · see citing works
Rousan, T. A., & Thadani, U. (2019) · European Cardiology Review · doi:10.15420/ecr.2018.26.1 · Cited by 45 · see citing works
Premkumar, M., Rangegowda, D., Vyas, T., Khumuckham, J. S., Shasthry, S. M., Thomas, S. S., Goyal, R., Kumar, G., & Sarin, S. K. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001219 · Cited by 45 · see citing works
Management of Refractory Angina Pectoris
Cheng, K., Sainsbury, P. A., Fisher, M., & de Silva, R. (2016) · European Cardiology Review · doi:10.15420/ecr.2016:26:1 · Cited by 43 · see citing works
Drug Therapy for Stable Angina Pectoris
Rousan, T. A., Mathew, S. T., & Thadani, U. (2017) · Drugs · doi:10.1007/s40265-017-0691-7 · Cited by 43 · see citing works
Liu, M., Long, X., Xu, J., Chen, M., Yang, H., Guo, X., Kang, J., Ouyang, Y., Luo, G., Yang, S., et al. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106515 · Cited by 41 · see citing works
Bigler, M. R., & Seiler, C. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153726 · Cited by 41 · see citing works
Relation of Higher Resting Heart Rate to Risk of Cardiovascular Versus Noncardiovascular Death
Alhalabi, L., Singleton, M. J., Oseni, A. O., Shah, A. J., Zhang, Z.-M., & Soliman, E. Z. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2016.11.059 · Cited by 40 · see citing works
Mak, K.-H., Vidal-Petiot, E., Young, R., Sorbets, E., Greenlaw, N., Ford, I., Tendera, M., Ferrari, R., Tardif, J.-C., Udell, J. A., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab011 · Cited by 39 · see citing works
Self-citationModulation of sympathetic activity and heart rate variability by ivabradine
da Silva, V. J. D., Tobaldini, E., Rocchetti, M., Wu, M. A., Malfatto, G., Montano, N., & Zaza, A. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv180 · Cited by 39 · see citing works
Rimoldi, S. F., Messerli, F. H., Cerny, D., Gloekler, S., Traupe, T., Laurent, S., & Seiler, C. A. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07250 · Cited by 39 · see citing works
Custodis, F., Roggenbuck, U., Lehmann, N., Moebus, S., Laufs, U., Mahabadi, A. A., Heusch, G., Mann, K., Jöckel, K., Erbel, R. M., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-015-0956-7 · Cited by 38 · see citing works
New Management Strategies in Heart Failure
OWENS, A. T., Brozena, S. C., & Jessup, M. L. (2016) · Circulation Research · doi:10.1161/circresaha.115.306567 · Cited by 38 · see citing works
Management of stable angina: A commentary on the European Society of Cardiology guidelines
Ambrosio, G., Mugelli, A., Lopez-Sendon, J. L., Tamargo, J. L., & Camm, A. J. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316648475 · Cited by 38 · see citing works
Nuding, S., Schröder, J., Presek, P., Wienke, A., Müller‐Werdan, U., Ebelt, H., & Werdan, K. (2017) · Shock · doi:10.1097/shk.0000000000000992 · Cited by 37 · see citing works
Ivabradine: A Review of Labeled and Off-Label Uses
Oliphant, C. S., Owens, R. E., Bolorunduro, O. B., & Jha, S. K. (2016) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-016-0178-z · Cited by 36 · see citing works
On behalf of the EUROASPIRE Investigators, Bacquer, D. D., Smedt, D. D., Kotseva, K., Jennings, C. S., Wood, D., Rydén, L., Gyberg, V., Shahim, B., Amouyel, P., et al. (2018) · European Journal of Epidemiology · doi:10.1007/s10654-018-0454-0 · Cited by 35 · see citing works
A pathophysiological compass to personalize antianginal drug treatment
Bertero, E., Heusch, G., Münzel, T. F., & Maack, C. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00573-w · Cited by 35 · see citing works
Zhang, C., Li, F., Yan, Y. Q., Huang, A., He, P., Lei, M., Wang, J., Huang, L., Liu, Z., Liu, J., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00253 · Cited by 34 · see citing works
Alternative interventions for refractory angina
Sainsbury, P. A., Fisher, M., & de Silva, R. (2017) · Heart · doi:10.1136/heartjnl-2015-308564 · Cited by 34 · see citing works
Ueng, K., Chiang, C., Chao, T., Wu, Y., Lee, W.-L., Li, Y., Ting, K.-H., Su, C.-H., Lin, H., Su, T., et al. (2023) · PubMed Central · doi:10.6515/acs.202301_39(1).20221103a · Cited by 34 · see citing works
The therapeutic role of ivabradine in heart failure
Badu-Boateng, C., Jennings, R., & Hammersley, D. J. (2018) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622318784556 · Cited by 34 · see citing works
Update of Pediatric Heart Failure
Watanabe, K., & Shih, R. S. (2020) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2020.06.004 · Cited by 33 · see citing works
Ivabradine in Cardiovascular Disease Management Revisited: a Review
Chen, C., Kaur, G., Mehta, P. K., Morrone, D., Godoy, L. C., Bangalore, S., & Sidhu, M. S. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07124-4 · Cited by 33 · see citing works
Update on medicines for smoking cessation
McDonough, M. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.038 · Cited by 33 · see citing works
Medical management of chronic stable angina
Wee, Y. S., Burns, K., & Bett, N. (2015) · Australian Prescriber · doi:10.18773/austprescr.2015.042 · Cited by 32 · see citing works
Augmentation of myocardial If dysregulates calcium homeostasis and causes adverse cardiac remodeling
Yampolsky, P., Koenen, M., Mosqueira, M., Geschwill, P., Nauck, S., Witzenberger, M., Seyler, C., Fink, T., Kruska, M., Bruehl, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11261-2 · Cited by 31 · see citing works
Godoy, L. C., Farkouh, M. E., Austin, P. C., Shah, B. R., Qiu, F., Jackevicius, C. A., Wijeysundera, H. C., Krumholz, H. M., & Ko, D. T. (2023) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2023.04.021 · Cited by 31 · see citing works
Barzilai, M., & Giris, J. (2015) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10213 · Cited by 31 · see citing works
- Authors
- Fox, K., Ford, I., Steg, P. G., Tardif, J.-C., Tendera, M., & Ferrari, R.
- Affiliations
- Inserm (FR)
- University of Glasgow (GB)
- Montreal Heart Institute (CA)
- University of Ferrara (IT)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2014-09-18
- Volume
- 371
- Issue
- 12
- Pages
- 1091-1099
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2153622558
- Cited by
- 486
- References
- 19
- Citations by year
- 2026: 10 · 2025: 16 · 2024: 30 · 2023: 34 · 2022: 29 · 2021: 29 · 2020: 27 · 2019: 44 · 2018: 35 · 2017: 49 · 2016: 95 · 2015: 68 · 2014: 18 · 2013: 1
- FWCI
- 52.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- HAL (submittedVersion)
- Institutional Research Information System University of Ferrara (University of Ferrara) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10149)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Rate Variability and Autonomic Control
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- ivabradine, stable coronary artery disease, heart rate reduction, cardiovascular mortality, myocardial infarction, bradycardia, non-inferiority, left ventricular dysfunction, target heart rate, drug safety and efficacy, atrial fibrillation
- MeSH terms
- Ivabradine, Adrenergic beta-Antagonists, Aged, Angiotensin-Converting Enzyme Inhibitors, Benzazepines, Cardiovascular Diseases, Coronary Artery Disease, Double-Blind Method, Drug Therapy, Combination, Female, Heart Failure, Heart Rate, Humans, Male, Middle Aged, Risk, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Kaplan-Meier Estimate, Intention to Treat Analysis, Angina, Stable
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
